Gert van der Hoek
In Memoriam - Editor, Senior Moderator
J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24827. [Epub ahead of print]
[h=1]Acute Flaccid Paralysis surveillance in Bosnia and Herzegovina: recent isolation of two Sabin like type 2 poliovirus.[/h] Fontana S1, Buttinelli G1, Fiore S1, Mulaomerovic M2, Aćimović J3, Amato C1, Delogu R4, Rezza G1, Stefanelli P1,5.
[h=3]Author information[/h]
[h=3]Abstract[/h]
The WHO Regional Commission for the Certification of Poliomyelitis Eradication has recently indicated Bosnia and Herzegovina (B&H) as a high risk country for transmission, following importation, of wild poliovirus (WPV) or circulating vaccine-derived poliovirus (cVDPV). We analyzed data on Acute Flaccid Paralysis (AFP) surveillance between 2007 to 2016, and the trend of polio immunization coverage in B&H.
The majority of AFP cases was recorded in 2016 suggesting an enhancement of the AFP surveillance activities. However, the decline in the immunization coverage, around 74%, and the isolation of two Sabin-like poliovirus type 2 strains, one of them close to a VDPV, require a particular attention in the area. Although B&H has successfully maintained its polio-free status since 2002 several challenges need to be addressed.
Note: "Sabin" refers to a type of poliovaccine.
[h=1]Acute Flaccid Paralysis surveillance in Bosnia and Herzegovina: recent isolation of two Sabin like type 2 poliovirus.[/h] Fontana S1, Buttinelli G1, Fiore S1, Mulaomerovic M2, Aćimović J3, Amato C1, Delogu R4, Rezza G1, Stefanelli P1,5.
[h=3]Author information[/h]
[h=3]Abstract[/h]
The WHO Regional Commission for the Certification of Poliomyelitis Eradication has recently indicated Bosnia and Herzegovina (B&H) as a high risk country for transmission, following importation, of wild poliovirus (WPV) or circulating vaccine-derived poliovirus (cVDPV). We analyzed data on Acute Flaccid Paralysis (AFP) surveillance between 2007 to 2016, and the trend of polio immunization coverage in B&H.
The majority of AFP cases was recorded in 2016 suggesting an enhancement of the AFP surveillance activities. However, the decline in the immunization coverage, around 74%, and the isolation of two Sabin-like poliovirus type 2 strains, one of them close to a VDPV, require a particular attention in the area. Although B&H has successfully maintained its polio-free status since 2002 several challenges need to be addressed.
Note: "Sabin" refers to a type of poliovaccine.